Learn More About Echo
HEALTHCARE & LIFE SCIENCES
Investment Banking for the Companies Building a Healthier Tomorrow
Echo Partners advises founder-owned and closely held companies on M&A and capital raises across North America, Europe and Asia Pacific. Our global market coverage connects clients with the buyers, investors and strategic partners best positioned to recognize the value of what they have built.
300+
Buyers & Investors in
Active Coverage
Global
Reach in North America, Europe & Asia Pacific
100%
Healthcare & Life Sciences Focused
Partners
Lead Every Client Engagement
Our Expertise
Echo Partners focuses exclusively on healthcare and life sciences. We serve founder-owned and closely-held companies across three service areas.
Private Capital
We raise equity, debt and structured capital for growth, expansion and shareholder liquidity, connecting clients with investors who understand healthcare and life sciences.
Explore More
.svg)
Mergers & Acquisitions (M&A)
Full, competitive sell-side processes run into the complete buyer universe, strategic and financial, across North America, Europe, and Asia Pacific. We run it wherever the right buyer sits.
Explore More
.svg)
Strategic Advisory
We advise executives and boards on licensing and partnership transactions, technology acquisitions, capital strategy, portfolio decisions and unsolicited approaches.
Explore More
Sector Clarity
Life Science Tools
Instruments, reagents and software platforms that accelerate target discovery and assay development.
CDMO / CRO
Contract development, manufacturing and research organizations that enable drug and device pipelines.
Medtech
Design and development of medical devices, implants and therapeutic delivery systems.
Medical Diagnostics
Assay, imaging and point-of-care test developers for disease detection and monitoring.
Biotech
Companies creating biologic therapies, genetic medicines and cell-based treatment platforms.
.png)
Pharmaceuticals
Small-molecule and specialty drug developers overseeing discovery, development and distribution.
Bioinformatics
Computational analysis and software tools transforming genomic and clinical data into insights.
Healthtech
Digital platforms, telemedicine and software solutions that enhance care delivery and engagement.
Healthcare Services
Clinical care, diagnostics and support services providers across outpatient and inpatient settings.
.png)
Transactions
Financial Advisor
Equity Financing
Financial Advisor
.png)
Equity Financing
$45M
Financial Advisor
.avif)
Equity Financing
$145M
Financial Advisor
Equity Financing
$55M
Financial Advisor
Equity & Debt Financing
Financial Advisor
Equity Financing
$70M
Financial Advisor
Equity Financing
$117M
Financial Advisor
Sell-Side M&A
$160M
Joint Lead Arranger
Debt Financing, Revolving Credit Facility
Financial Advisor
Sell-Side M&A
The Latest From Echo
PRESS RELEASE
July 24, 2026
2026 Q2 Healthcare Market Report
PRESS RELEASE
May 13, 2026
2026 Q1 Healthcare Market Report
The Latest From Echo
Expertise At Your Fingertips
Sign up to receive our latest industry insights, news, and more.
Oops! Something went wrong while submitting the form.
Quick Links
.svg)
Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Echo Partners is not a registered broker-dealer, and Finalis Securities LLC and Echo Partners are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.
www.echopartners.io (the "Echo Partners Website") is a website operated by Echo Partners. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities’ registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and Echo Partners along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.
Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis Form Customer Relationship Summary (“Form CRS”) describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC.
©Copyright 2026. Echo Partners. All Rights Reserved.